Thomas J Jackson1, Gabriel Chow2, Mohnish Suri3, Philip Byrd4, Malcolm R Taylor4, William P Whitehouse1,2. 1. School of Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK. 2. Nottingham Children's Hospital, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK. 3. Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK. 4. School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Abstract
AIM: To assess the relationship between genotype and neurological progression in ataxia-telangiectasia (A-T). METHODS: Clinical and laboratory data were extracted retrospectively from the records of patients attending the UK National Ataxia-Telangiectasia Clinic. Neurological assessments were performed using the A-T Index (Crawford Score) and the A-T Neurological Examination Scale Toolkit (A-T NEST). Variables influencing phenotype were identified by using an information-theoretic approach starting from a maximal model to generate estimates of coefficients for each variable. Per-individual progression was assessed for patients with three or more clinic attendances. RESULTS: The genotype could be determined for 125/135 patients. Crawford and A-T NEST scores were well correlated. For both scoring systems the estimated coefficients were significantly positive for Age x kinase activity but not Age x protein expression. Unlike the per-genotype analysis, the individual progression of neurological scores in the 34 patients that attended on three or more occasions was not smooth and linear (and in some cases improved over time). INTERPRETATION: Residual kinase activity confers a milder phenotype but there is no difference between kinase-dead and protein-null genotypes. The non-linear progression of individual patients' neurological scores may reflect biological complexity, day-to-day variability, limitations of the assessment methods or a combination of all three.
AIM: To assess the relationship between genotype and neurological progression in ataxia-telangiectasia (A-T). METHODS: Clinical and laboratory data were extracted retrospectively from the records of patients attending the UK National Ataxia-Telangiectasia Clinic. Neurological assessments were performed using the A-T Index (Crawford Score) and the A-T Neurological Examination Scale Toolkit (A-T NEST). Variables influencing phenotype were identified by using an information-theoretic approach starting from a maximal model to generate estimates of coefficients for each variable. Per-individual progression was assessed for patients with three or more clinic attendances. RESULTS: The genotype could be determined for 125/135 patients. Crawford and A-T NEST scores were well correlated. For both scoring systems the estimated coefficients were significantly positive for Age x kinase activity but not Age x protein expression. Unlike the per-genotype analysis, the individual progression of neurological scores in the 34 patients that attended on three or more occasions was not smooth and linear (and in some cases improved over time). INTERPRETATION: Residual kinase activity confers a milder phenotype but there is no difference between kinase-dead and protein-null genotypes. The non-linear progression of individual patients' neurological scores may reflect biological complexity, day-to-day variability, limitations of the assessment methods or a combination of all three.
Authors: Hannah L McGlashan; Rob A Dineen; Sofia Szeszak; William P Whitehouse; Gabriel Chow; Andrew Love; Gill Langmack; Heather Wharrad Journal: Br J Radiol Date: 2018-05-10 Impact factor: 3.039
Authors: Harvey Perez; May F Abdallah; Jose I Chavira; Angelina S Norris; Martin T Egeland; Karen L Vo; Callan L Buechsenschuetz; Valentina Sanghez; Jeannie L Kim; Molly Pind; Kotoka Nakamura; Geoffrey G Hicks; Richard A Gatti; Joaquin Madrenas; Michelina Iacovino; Peter J McKinnon; Paul J Mathews Journal: Elife Date: 2021-11-01 Impact factor: 8.713
Authors: Katherine Schon; Nienke J H van Os; Nicholas Oscroft; Helen Baxendale; Daniel Scoffings; Julian Ray; Mohnish Suri; William P Whitehouse; Puja R Mehta; Natasha Everett; Leonardo Bottolo; Bart P van de Warrenburg; Philip J Byrd; Corry Weemaes; Michel A Willemsen; Marc Tischkowitz; A Malcolm Taylor; Anke E Hensiek Journal: Ann Neurol Date: 2019-02 Impact factor: 10.422
Authors: Anoopum S Gupta; Anna C Luddy; Nergis C Khan; Sara Reiling; Jennifer Karlin Thornton Journal: Cerebellum Date: 2022-03-16 Impact factor: 3.847
Authors: H Donath; S Woelke; R Schubert; M Kieslich; M Theis; G Auburger; R P Duecker; S Zielen Journal: Cerebellum Date: 2021-04-24 Impact factor: 3.847